Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool
NCT00792415 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-02-11
Summary
The purpose of this study is to assess the validity and reliability of an abstinence syndrome assessment tool used in pediatric patients with iatrogenic opioid dependence.
Conditions
- Substance Withdrawal Syndrome
Sponsors & Collaborators
-
Banner Health
lead OTHER
Principal Investigators
-
Teri Reyburn-Orne, RN, MSN, PNP · Banner Children's Hospital at Banner Desert Medical Center
Eligibility
- Min Age
- 2 Weeks
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2010-04-30
- Completion
- 2010-12-31
Countries
- United States
Study Locations
More Related Trials
-
Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia
NCT00539123 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder
NCT04737603 ·Status: WITHDRAWN ·Phase: PHASE2
-
Linking Opioid Dependent Patients From Inpatient Detoxification to Primary Care
NCT01751789 ·Status: COMPLETED ·Phase: NA
-
Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their Mothers
NCT01889121 ·Status: COMPLETED
-
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
NCT00000240 ·Status: COMPLETED ·Phase: PHASE2
-
Activity Monitoring Assessment of Opiate Withdrawal - 4
NCT00000335 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
NCT00000230 ·Status: COMPLETED ·Phase: PHASE2
-
Parenting Young Children Study
NCT05180487 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Multiple Dose Methadone in Children Treated for Opiate Withdrawal
NCT01945736 ·Status: COMPLETED
-
Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
NCT02411357 ·Status: COMPLETED ·Phase: NA
-
RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure
NCT02334111 ·Status: COMPLETED ·Phase: NA
-
Workforce and System Change to Treat Adolescent Opioid Use Disorder Within Integrated Pediatric Primary Care
NCT06477848 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Long-Term Treatment of Opioid Use Disorder
NCT05534815 ·Status: RECRUITING ·Phase: NA
-
Contingency Management for Opioid Use Disorder in Inpatients at Assiut University Hospital
NCT07208266 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Development of an Opioid Withdrawal Clinical Outcome Assessment
NCT07094672 ·Status: NOT_YET_RECRUITING
-
Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions
NCT04049799 ·Status: COMPLETED
-
Science-Based Treatment for Opioid-Dependent Adolescents
NCT00182572 ·Status: UNKNOWN ·Phase: PHASE2
-
Prevention Interventions for Opioid Misuse
NCT04550715 ·Status: COMPLETED ·Phase: NA
-
Distress Tolerance and Buprenorphine
NCT01556087 ·Status: COMPLETED ·Phase: PHASE3
-
Youth Opioid Recovery Support: Improving Care Systems
NCT04015115 ·Status: COMPLETED ·Phase: NA
-
An Adherence Tool to Manage Narcotic -Addicted HIV Patients
NCT02194764 ·Status: COMPLETED ·Phase: NA
-
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
NCT05027919 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants
NCT05493475 ·Status: COMPLETED ·Phase: NA
-
Benzodiazepine Discontinuation in Opioid Agonist Therapy
NCT04109118 ·Status: COMPLETED ·Phase: PHASE2
-
Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine
NCT04611659 ·Status: UNKNOWN ·Phase: NA